Efficacy and Safety of [(225)Ac]Ac-PSMA-617 Augmented [(177)Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Highly Advanced mCRPC with Poor Prognosis

por Rosar, Florian, Krause, Jonas, Bartholomä, Mark, Maus, Stephan, Stemler, Tobias, Hierlmeier, Ina, Linxweiler, Johannes, Ezziddin, Samer, Khreish, Fadi
Publicado 2021

A Structure‐Activity Relationship Study of Bimodal BODIPY‐Labeled PSMA‐Targeting Bioconjugates

por Stemler, Tobias, Hoffmann, Caroline, Hierlmeier, Ina M., Maus, Stephan, Krause, Elmar, Ezziddin, Samer, Jung, Gregor, Bartholomä, Mark D.
Publicado 2021

Value of Combined PET Imaging with [(18)F]FDG and [(68)Ga]Ga-PSMA-11 in mCRPC Patients with Worsening Disease during [(177)Lu]Lu-PSMA-617 RLT

por Khreish, Fadi, Ribbat, Kalle, Bartholomä, Mark, Maus, Stephan, Stemler, Tobias, Hierlmeier, Ina, Linxweiler, Johannes, Schreckenberger, Mathias, Ezziddin, Samer, Rosar, Florian
Publicado 2021